Global Peripheral Vascular Devices Market 2015-2019
About Peripheral Vascular Devices
Peripheral vascular disease is a condition characterized by damage to or blockage in the peripheral blood vessels. This disease may result in the form of blood clots such as deep vein thrombosis, inflammation, or narrowing and blockage of the blood vessels. In case the peripheral vascular disease affects only the arteries, the condition is known as PAD. PAD is also considered one of the most serious complications in patients with diabetes. It is characterized by narrowed arteries due to the accumulation of plaques (composed of fat, cholesterol, and fibrous tissue) that results in reduced blood flow to the brain, organs, and limbs, especially the legs. PAD is known to increase the risk of stroke and heart attack by up to six times. The devices used for the treatment of peripheral vascular disease include stents, balloon catheters, CTO, atherectomy devices, venacava filters, and grafts.
TechNavio's analysts forecast the global peripheral vascular devices market to grow at a CAGR of 7.29% over the period 2014-2019.
Covered in this Report
The global peripheral vascular devices market is divided into six segments: peripheral vascular stents, PTA balloon catheters, aortic stent grafts, atherectomy devices, embolic protection devices, and others (synthetic surgical grafts, chronic total occlusion devices, inferior vena cava filters, and PTA guidewires).
TechNavio's report, the Global Peripheral Vascular Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key Regions
Technavio Announces the Publication of its Research Report – Global Peripheral Vascular Devices Market 2015-2019
Technavio recognizes the following companies as the key players in the global peripheral vascular devices market: Abbott Laboratories Ltd., Boston Scientific Corp., C. R. Bard Inc., Cordis Corp. and Medtronic Inc.
Other Prominent Vendors in the market are: AngioDynamics, AngioScore, Aptus Endosystems, Argon Medical Devices, Bolton Medical, Cook Medical, Endologix, JOTEC, LeMaitre Vascular, Lombard Medical Technologies, Teleflex, Terumo, TriVascular Technologies, Volcano and W.L. Gore & Associates
Commenting on the report, an analyst from Technavio’s team said: “The use of bio-absorbable stents is one of the major trends in the market. Bio-absorbable stents eliminate the problems associated with durable polymer stents, as they are absorbed by the body.”
According to the report, the increased incidence of PVD is a major contributor to the growth of the market. It is estimated that nearly 200 million people worldwide are affected by PVD, a number that is expected to rise as the population ages.
Further, the report states that the fragmented nature of the market is its primary challenge. Global and regional vendors have similar product offerings and compete to gain the largest shares, leading to decreased profitability.
Abbott Laboratories Ltd, Boston Scientific Corp, C. R. Bard Inc, Cordis Corp, Medtronic Inc, AngioDynamics, AngioScore, Aptus Endosystems, Argon Medical Devices, Bolton Medical, Cook Medical, Endologix, JOTEC, LeMaitre Vascular, Lombard Medical Technologies, Teleflex, Terumo, TriVascular Technologies, Volcano, W.L. Gore & Associates